Perspective Therapeutics Cash Flow Statement (2010-2026) | CATX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	1.35M	-2.24M	-1.60M	-1.35M	-2.08M	-4.07M	-2.27M	-1.47M	-1.62M	-0.78M	-5.18M	-0.46M	-0.49M				0.51M			-26.19M
Depreciation and Depletion (Quarter)		0.06M	-0.08M	0.06M	0.13M	0.07M	0.14M	0.18M	0.24M	0.26M	-0.45M	0.35M	0.57M	0.67M	-1.58M
Share-based Compensation (Quarter)		0.60M	0.18M	0.16M	0.15M	0.47M	0.50M	1.37M	1.05M	0.42M	0.69M	0.62M	0.59M	1.95M	2.06M	2.10M	2.40M	2.16M	2.31M	2.55M
Deferred Taxes (Quarter)								-10.50M			7.85M				-2.10M
Gains from Investment Securities (Quarter)	4.51M		7.27M		-0.65M	0.00M	0.15M	-0.02M	0.01M	13.83M	609.62M	-0.03M			1,994.93M	-0.14M	-0.08M	-0.01M	0.24M	-0.08M
Asset Writedowns and Impairment (Quarter)										0.30M	0.30M			-0.06M	0.06M				10.00M
Non-cash Items (Quarter)	0.98M	4.21M	4.06M	4.04M	0.00M			12.99M	35.02M	2.27M	6,671.26M				3,818.60M				5.44M
Change in Interest Receivables (Quarter)															0.88M	0.07M	0.21M	0.02M	-0.16M	0.39M
Cash from Operations (Quarter)		-2.08M	2.68M	-1.42M	-4.32M	-1.76M	-6.09M	-9.72M	-8.07M	-10.11M	-9.01M	13.85M	-8.90M	3.37M	-26.61M	-21.58M	-19.95M	-16.29M	-24.66M	-31.47M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)		0.01M	-0.00M	0.01M	0.02M	0.01M	0.02M	0.01M	0.01M	0.01M	0.01M	0.01M	0.00M
Depreciation & Amortization (CF) (Quarter)		0.06M	-0.08M	0.07M	0.07M	0.07M	0.14M	0.19M	0.26M	0.26M	0.30M	0.36M	0.57M	0.67M	0.71M	0.73M	0.73M	0.78M	1.01M	1.13M
Change in Working Capital
Change in Receivables (Quarter)		-0.11M	0.07M	0.49M	-0.04M	-0.40M	-0.24M	0.00M	-0.25M	0.62M	-0.57M	-0.17M	-0.81M	0.15M	-0.22M	-0.04M	0.15M	-0.05M	-0.17M	0.05M
Change in Inventory (Quarter)		0.80M	-1.26M	-0.08M	1.92M	0.10M	0.08M	-0.13M	-0.02M	-0.11M	-0.10M	-0.03M	0.02M
Change in Accured Expenses (Quarter)		0.04M	-1.64M	-0.08M	0.12M	1.53M	0.57M	-0.59M	1.03M	-1.12M	2.26M	-0.88M	0.12M	15.70M	-13.05M	-2.57M	2.12M	1.67M	-1.09M	-4.21M
Investing Activities
Capital Expenditures (Quarter)		0.05M	-0.09M	0.03M	0.13M	0.09M	0.15M	0.20M	-0.18M	0.96M	0.09M		10.09M	-10.06M	54.39M	0.01M	0.04M	0.04M	0.05M
Sales of Property, Plant and Equipment (Quarter)
Change in Intangibles (Quarter)					0.01M	0.02M
Acquisitions (Quarter)								2.70M
Change in Acquisitions & Divestments (Quarter)							12.54M	22.76M					38.23M		40.51M	21.70M	49.82M	48.15M	-119.67M	47.64M
Cash from Investing Activities (Quarter)		-0.05M	35.18M	-0.03M	-0.15M	-35.17M	-28.84M	25.26M	-0.57M	-0.23M	-0.09M	-47.30M	-3.29M	-29.74M	-138.60M	-5.57M	4.26M	13.99M	28.54M	-109.55M
Financing Activities
Other financing activities (Quarter)								0.07M
Debt Issuance and Repayment
Long-Term Debt Repayments (Quarter)								0.01M	0.02M	0.02M	0.01M	0.01M	0.01M	0.02M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Change in Capital Stock
Shares Issued (Quarter)			-0.03M	0.06M	-56.32M	0.03M	0.03M				0.40M	0.13M	0.13M	0.64M	0.36M		0.14M	0.23M	-0.37M	0.29M
Preferred Shares Issued (Quarter)
Dividend Payments
Dividends Paid - Common (Quarter)
Misc.
Cash from Financing Activities (Quarter)			0.03M			0.03M	0.03M	-0.08M	0.51M	0.00M	0.35M	166.33M	122.08M	0.63M	0.34M	9.97M	0.13M	0.21M	-0.01M	164.36M
Change in Cash (Quarter)		-2.14M	37.89M	-1.45M	-4.46M	-36.90M	-34.90M	15.46M	-8.13M	-10.34M	-8.74M	132.88M	109.89M	-25.74M	-164.86M	-17.17M	-15.56M	-2.09M	3.87M	23.34M
Free Cash Flow (Quarter)		-2.14M	2.77M	-1.45M	-4.45M	-1.85M	-6.24M	-9.92M	-7.89M	-11.07M	-9.10M	13.85M	-18.99M	13.43M	-81.00M	-21.59M	-19.99M	-16.33M	-24.71M	-31.47M
Net Cash Flow (Quarter)		-2.14M	37.89M	-1.45M	-4.46M	-36.90M	-34.90M	15.46M	-8.13M	-10.34M	-8.74M	132.88M	109.89M	-25.74M	-164.86M	-17.17M	-15.56M	-2.09M	3.87M	23.34M

Research Tools

Perspective Therapeutics Cash Flow Statement (2010-2026) | CATX

Create an account

Sign In

Reset Password